Zantac Injury Lawyers

Since the summer of 2019, the U.S. Food and Drug Administration (FDA) has been investigating the potential harmful side-effects of the usage of prescription and over-the-counter ranitidine medicines, including the popular heartburn brand, Zantac. On September 13, 2019, the FDA issued a statement alerting the public to their discovery of an impurity called N-nitrosodimethylamine (NDMA) in some ranitidine medicines, including popular over-the-counter heartburn medication, Zantac. NDMA is classified as a probable human carcinogen and a known environmental contaminant.

On November 22, 2019, the FDA alerted health care professionals and patients to multiple voluntary recalls of Zantac (ranitidine) by manufacturers including Sanofi and GlaxoSmithKline. These products are being recalled due to potentially unacceptable levels of NDMA. The FDA has advised drug companies to recall their medicines if sample tests reveal NDMA above the acceptable daily intake levels.

Multiple lawsuits have been filed against manufacturers of Zantac. Plaintiffs allege that the drugmakers Sanofi and Boerhinger Ingelheim manufactured, marketed and sold a product they knew or reasonably should have known, was contaminated with a known carcinogen.   Furthermore, plaintiffs accuse the drugmakers of choosing not to disclose the risk of such contamination to consumers or the government.  The lawsuits have alleged that the company knew or should have known that the products had been contaminated with an industrial chemical known to cause cancer.

Your Legal Options

If you or a loved one has been recently diagnosed with any of the above–referenced conditions following the use of Zantac, call Gruber Law Offices. We are working in partnership with a pharmaceutical-focused national, award-winning  law firm. Our team is available 24/7 to discuss your legal options. Call us now for a free and confidential consultation.